Últimos Artículos de Endocrine Related Cancer
- Clinical and basic research implications of the article ‘IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer’
- Subgroup analysis of steadily increased trends in medullary thyroid carcinoma incidence and mortality in the USA, 2000–2020: a population-based retrospective cohort study
- Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma
- Clinical utility of plasma cell-free DNA in pancreatic neuroendocrine neoplasms
- Transformation of G1-G2 neuroendocrine tumors to neuroendocrine carcinomas following peptide receptor radionuclide therapy
- Bioengineered in vitro three-dimensional tumor models in endocrine cancers
- Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
- Immunotherapy for endocrine tumours: a clinician’s perspective
- Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma
- Immunophenotyping with high-dimensional flow cytometry identifies Treg cell subsets associated with recurrence in papillary thyroid carcinoma
- Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms
- ERRATUM: Mutational landscape of non-functional adrenocortical adenomas
- Sexual dimorphism in medullary thyroid cancer aggressiveness
- Growth hormone and radiation therapy: friend, foe, or both?
- Impact of sex on treatment decisions and outcome in patients with neuroendocrine neoplasms
- Beyond the three P’s: adrenal involvement in MEN1
- NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas
- Genomic profiling of primary and metastatic thyroid cancers
- Gender-affirming care and endocrine-related cancers
- Steroid profile in patients with breast cancer and in mice treated with mifepristone